---
inFeed: true
hasPage: true
inNav: true
inLanguage: en
starred: false
keywords:
  - therapeutics
  - metabolostasis
  - disorders
  - exomeseq
  - copper
  - sequencing
  - genes
  - disease
  - metabolic
  - deficiency
description: 'METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases. Current research focuses on disorders of copper metabolism, an essential micro-nutrient whose deficiency or excess leads to immune dysfunction, heart disease, tumor development as well as dramatic neurodegeneration.'
datePublished: '2015-12-19T19:57:42.174Z'
dateModified: '2015-12-19T19:29:20.890Z'
author: []
related: []
app_links: []
title: 'Home '
authors: []
publisher:
  name: MetaboloStasis Therapeutics
  domain: www.metabolostasis.com
  url: 'http://www.metabolostasis.com'
  favicon: 'http://nebula.phx3.secureserver.net/c6714f9bd306e3c0b2c809a982b77815?AccessKeyId=A0CE1EF33ABC5529819D&disposition=0&alloworigin=1'
sourcePath: _posts/2015-12-19-home.md
published: true
url: home/index.html
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Home</h1><p>METABOLOSTASIS THERAPEUTICS is committed to the development of novel therapeutics for the treatment of rare diseases. Current research focuses on disorders of copper metabolism, an essential micro-nutrient whose deficiency or excess leads to immune dysfunction, heart disease, tumor development as well as dramatic neurodegeneration.</p><img src="https://s3-us-west-2.amazonaws.com/the-grid-img/p/d8643cbaf10fc343fa68c302cbd40f69de12c466.jpg" /></article>